These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6393974)

  • 1. Fatty acid composition and action of serum lipoproteins on the PGI2-formation after various oil diets in hyperlipoproteinemia.
    Honigmann G; Schimke E; Schliack V; Beitz J; Förster W; Fischer S; Hora C; Hanefeld M
    Biomed Biochim Acta; 1984; 43(8-9):S443-6. PubMed ID: 6393974
    [No Abstract]   [Full Text] [Related]  

  • 2. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V; Klör HU; Wechsler JG; Ditschuneit H
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of low density and high density lipoprotein cholesterol by fat-modified diets. A survey of recent findings.
    Vessby B; Lithell H; Boberg J
    Hum Nutr Clin Nutr; 1982; 36(3):203-11. PubMed ID: 6749766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias.
    Canzler H; Bojanovski D
    Artery; 1980; 8(2):171-8. PubMed ID: 7458684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV].
    Romics L; Karádi I; Simonyi E
    Orv Hetil; 1980 Oct; 121(43):2629-31. PubMed ID: 7208011
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the phenotyping system of hyperlipoproteinemias. Evaluation of a new method by enzymic staining of lipids in serum lipoproteins separated by electrophoresis on agarose.
    Ohno F; Suehiro T; Uga S; Kawada M; Takamatsu K; Yasuoka N; Yamano T
    Jpn J Med; 1983 Aug; 22(3):200-5. PubMed ID: 6620708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipoprotein pattern after SAMe-treatment.
    Rini GB; Di Fede G; Rotolo G; Rizzo G; Mascellino MR; Affronti M; Delle Vedove G
    Boll Soc Ital Biol Sper; 1987 Oct; 63(10):919-22. PubMed ID: 3447603
    [No Abstract]   [Full Text] [Related]  

  • 9. Low linolenate and commercial soybean oils diminish serum HDL cholesterol in young free-living adult females.
    Lu Z; Hendrich S; Shen N; White PJ; Cook LR
    J Am Coll Nutr; 1997 Dec; 16(6):562-9. PubMed ID: 9430084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the concentration and composition of lipids and lipoproteins in primary hyperlipoproteinemia during treatment with bezafibrate.
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(8):1185-90. PubMed ID: 6685498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breed differences in nutritionally induced hyperlipoproteinemia in the rabbit.
    Lacombe C; Nibbelink M
    Artery; 1980; 7(5):419-27. PubMed ID: 7213026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin E and lipoproteins in hyperlipoproteinemia.
    Lambert D; Mourot J
    Atherosclerosis; 1984 Dec; 53(3):327-30. PubMed ID: 6529449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of diet and drug therapy on the level of high density lipoprotein cholesterol in patients with primary hyperlipoproteinemia].
    Padosh D; Kustosh D; Puchok I; Dem'ianova N; Audikovski M
    Klin Med (Mosk); 1981 Sep; 59(9):45-8. PubMed ID: 7311430
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fatty acid composition of phosphatidylcholine and levels of lipids and lipoproteins in hyperlipoproteinemia. I. Relation to HDL lipoprotein].
    Zák A; Zeman M; Tvrzická E
    Cas Lek Cesk; 1998 Jun; 137(12):368-71. PubMed ID: 9721473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sulfinpyrazone and lipoproteins: absence of effects on serum lipids in hyperlipoproteinemias of types II and IV].
    Sommariva D; Scotti L; Baroni L; Beggi P; Fasoli A
    Clin Ter; 1980 Mar; 92(6):649-55. PubMed ID: 7460493
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
    Staprans I; Pan XM; Rapp JH; Feingold KR
    Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of cod liver oil as a source of n-3 fatty acids on lipoproteins and blood viscosity in patients with primary hyperlipoproteinemia].
    Giorgi AA; Wikinski R; Kartin D; López GI; Schreier L; D'Alessandro G; Paglione AM; Halperin H; Sermukslis de Smud B
    Medicina (B Aires); 1988; 48(5):479-86. PubMed ID: 3255039
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fatty acid composition of plasma phosphatidylcholine and levels of lipids and lipoproteins in hyperlipoproteinemia. II. Relation with B lipoproteins].
    Zák A; Zeman M; Tvrzická E
    Cas Lek Cesk; 1998 Jun; 137(13):400-3. PubMed ID: 9748733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 20. Saturated fats and blood lipids: new slant on an old story.
    Hayes KC
    Can J Cardiol; 1995 Oct; 11 Suppl G():39G-46G. PubMed ID: 7585292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.